Status
ACTIVE
Global HQ
Waltham, United States
Countries of investment
- USA
- Denmark
- Finland
- France
- Germany
- Sweden
- Japan
Investment stages
- Seed
- Series A
- Series B
- Series C
Industries
- Life Sciences
- Health Tech
- Digital Health
About
Agent Capital is a venture capital firm
Agent Capital is a venture capital firm
Investment Thesis
Agent Capital is a healthcare venture capital firm focused on novel and differentiated therapeutics and treatments addressing unmet patient needs. The firm invests across all development stages in areas including rare diseases, oncology, neurology, and immunology, partnering closely with scientists and entrepreneurs to drive healthcare innovation.
Manager's Experience
Agent Capital is a healthcare venture capital firm focused on novel therapeutics addressing unmet patient needs in areas like rare diseases, oncology, neurology, and immunology. They guide biotech companies proactively through milestones and exits with a deep understanding of biopharma pipeline pressures.
Team
https://www.agentcapital.com/about/?utm_source=chatgpt.com
Portfolio
Affini-T
AshiBio
Carbon Biosciences
Carisma Therapeutics
Cerevance
Cyrus Biotechnology
Dice Therapeutics
Dragonfly Therapeutics
Entrada Therapeutics
Flare Therapeutics
Foresight Diagnostics
Freenome
Hinge Bio
ImCheck Therapeutics
Immunitas Therapeutics
Interius BioTherapeutics
Mediar Therapeutics
Metagenomi
Orbital Therapeutics
Orbus Therapeutics
Orchard Therapeutics
Palvella Therapeutics
Pliant Therapeutics
Precision Biosciences
Primrose Bio
Pyxis Oncology
Q32 Bio
Skyhawk Therapeutics
Star Therapeutics
TRex Bio
Verge Genomics
ViTToria Biotherapeutics
Zenas Biopharma